These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22949781)

  • 21. The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Anguera I; Dallaglio P; Sabaté X; Nuñez E; Gracida M; Di Marco A; Sugrañes G; Cequier A
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):486-94. PubMed ID: 24215374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is this pacemaker working properly? Prolongation of the atrial escape interval following activation of the ventricular safety pacing algorithm in a dual-chamber implantable cardioverter defibrillator with atrial-based, lower rate timing.
    Johri AM; Baranchuk A; Simpson CS; Redfearn DP; Abdollah H
    Can J Cardiol; 2008 Jul; 24(7):e43-4. PubMed ID: 18612507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
    Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
    Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S; Aktas M; Mutluer FO; Guler TE; Dervis E; Argan O; Celikyurt U; Agir A; Vural A
    Acta Cardiol; 2019 Jun; 74(3):246-251. PubMed ID: 30058473
    [No Abstract]   [Full Text] [Related]  

  • 27. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
    Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic study: its predictive value for ventricular arrhythmias.
    Gold DR; Catanzaro JN; Makaryus JN; Waldman C; Sauer WH; Sison C; Makaryus AN; Altman E; Jadonath R; Beldner S
    Tex Heart Inst J; 2010; 37(3):291-6. PubMed ID: 20548804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A devices' game of thrones: cardiac resynchronization therapy vs. pacemaker.
    Moura-Ferreira S; Gonçalves H; Oliveira M; Primo J; Fonseca P; Ribeiro J; Santos E; Pelicano N; Martins D; Gama V
    Europace; 2017 Dec; 19(12):2042-2046. PubMed ID: 28430911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of cardioversion therapy in patients with implanted cardioverter defibrillators.
    Nathan AW
    Am Heart J; 1994 Apr; 127(4 Pt 2):1046-51. PubMed ID: 8160579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P).
    Regoli F; Graf D; Schaer B; Duru F; Ammann P; Stefano LMDS; Naegli B; Burri H; Zbinden R; Krasniqi N; Fromer M;
    BMC Cardiovasc Disord; 2019 Jun; 19(1):146. PubMed ID: 31208342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Automatic implantable cardioverter-defibrillator (AICD) and antitachycardia pacemaker (Tachylog 651) in the treatment of ventricular tachyarrhythmias].
    Gerckens U; Manz M; Funke HD; Kirchhoff PG; Lüderitz B
    Z Kardiol; 1987 Apr; 76(4):211-6. PubMed ID: 3604373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
    Adler A; Rosso R; Meir I; Viskin S
    Europace; 2013 Mar; 15(3):362-5. PubMed ID: 23118003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator.
    Wietholt D; Block M; Isbruch F; Böcker D; Borggrefe M; Shenasa M; Breithardt G
    J Am Coll Cardiol; 1993 Mar; 21(4):885-94. PubMed ID: 8185728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
    Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
    G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of antitachycardia pacing with defibrillation.
    Lüderitz B
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):312-6. PubMed ID: 1706844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.
    Bennett MT; Leader N; Sapp J; Parkash R; Gardner M; Healey JS; Thibault B; Sterns L; Essebag V; Birnie D; Sivakumaran S; Nery P; Andrade JG; Krahn AD; Tang A
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005921. PubMed ID: 29618476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
    Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.